Join medtech VCs and CEOs as they delve into strategies for positioning your medtech company to attract investors, collaborators, and acquirers. Intellectual Property (IP) is critical for medtech companies to attract funding, strategic partners, and navigate an exit through M&A or IPO. To become attractive funding or M&A targets, medtech companies must prioritize de-risking and aligning their commercial, regulatory, and IP strategies. Gain insights into best practices and pitfalls to avoid when building strategic patent portfolios to close funding, stay competitive, and secure a successful exit.
